Testicular cancer Flashcards

(44 cards)

1
Q

Testicular cancer RF

A

1) crypto-orchidism (undescended testes at birth)
*Both testes at risk, including descended testes
2) Agent orange
3) infertility
*Not smoking or obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Half life of beta-HCG and AFP

A

HCG half life one day
AFP 5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Management of primary mediastinal NSGCT

A
  • VIP x 4 cycles (Preferred - Bleo not used Require surgery and post-op complications higher with BEP)
    OR BEP x 4 cycles
  • Consult thoracic surgery for resection of residual mediastinal disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Primary mediastinal seminoma management

A

BEP
Follow residual mass with surveillance CT chest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cytogenetic finding associated with testicular cancer

A

isochromosome 12p

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Testicular mass tissue sampling

A
  • inguinal orchiectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lymphatic spread of testicular cancer

A
  • to ipsilateral RP nodes, never to inguinal or pelvic unless anatomy has been altered (cryptoorchidism, bad urologist doing testicular biopsy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

1) general management of primary mediastinal NSGCT 2) preferred systemic therapy

A
  • VIP (not bleomycin)
  • thoracic surgery then resects residual mediastinal disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

management of primary mediastinal seminoma

A
  • good risk disease
  • BEP, then you follow residual mass w/ CT chest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

clinical significance of path showing seminoma with AFP elevation

A
  • non seminoma component, by definition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

other cause of beta-HCG elevation

A

marijuana

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What to think with very high beta-HCG

A

choriocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Seminoma risk categories

A
  • only 2: good or intermediate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pulmonary mets in seminoma are classified as

A

good risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of bleo toxicity in terms of continuing treatment

A

IF poor or intermediate risk, switch to ifosfamide
IF good risk, drop bleo and don’t substitute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

1) Stage 1 seminoma mgmt options 2) Preferred option

A
  • surveillance (preferred)
  • consider XRT or 1-2 cycles carboplatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Stage 2 seminoma mgmt

A

BEP x 3 cycles
EP x 4 cycles
(CONFIRM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Stage 3 seminoma mgmt

A

BEP x 4 cycles
VIP x 4 cycles
(CONFIRM)

19
Q

What defines Good risk seminoma?

A

All of the following:
Any primary site
No metastases to organs other than the lungs and/or lymph nodes
Normal serum AFP
***Just remember that intermediate is presence of nonpulmonary visceral mets

20
Q

Intermediate risk seminoma

A

All of the following:
Any primary site
Metastases to organs other than the lungs and/or lymph nodes
Normal serum AFP

21
Q

What defines Good risk NSGCT?

A

All of the following:
Testicular or retroperitoneal primary tumors
No metastases to organs other than the lungs and/or lymph nodes
Serum AFP <1000 ng/mL, beta-hCG <5000 milli-international units/mL, and LDH <3 times the upper limit of normal*

22
Q

Intermediate risk NSGCT

A

All of the following:
Testicular or retroperitoneal primary tumors
No metastases to organs other than the lungs and/or lymph nodes
Serum AFP 1000 to 10,000 ng/mL* or
Serum beta-hCG 5000 to 50,000 milli-international units/mL* or
LDH 3 to 10 times the upper limit of normal*

23
Q

What defines poor risk NSGCT?

A

Any of the following:
Mediastinal primary with or without metastases
Metastases to organs other than the lungs and/or lymph nodes
Serum AFP >10,000 ng/mL*
Serum beta-hCG >50,000 milli-international units/mL*
LDH more than 10 times the upper limit of normal*

24
Q

Size cutoff for residual mass in seminoma

25
Management of residual mass in seminoma
IF residual mass <3cm → active surveillance IF residual mass >3cm → PET IF PET negative → active surveillance IF PET positive → surgery
26
Stage II seminoma mgmt
Stage IIA RT (preferred -Including para-aortic and ipsilateral iliac lymph nodes to a dose of 30 Gy) chemotherapy (EP for 4 cycles vs. BEP x 3 cycles) Stage IIB Given elevated beta-HCG, BEP x 3 cycles vs. EP x 4 cycles (Preferred)
27
Germ cell subtype in which PET/CT has utility
Only in seminoma
28
NSGCT and radiosensitivity
NSGCT is radioresistant so radiation not typically offered
29
Stage IIB and IIC NSGCT mgmt
BEP x 3 cycles (Preferred) vs. EP x 4 cycles IF residual mass >1cm, RPLND
30
Stage IIA NSGCT mgmt
RPLND IF deferring RPLND, BEP 3 cycles
31
Advanced NSGCT mgmt
- Good risk - BEP 3 cycles - Intermediate and poor risk disease BEP 4 cycles
32
Size cutoff for residual mass in NSGCT + management
1) 1 cm 2) IF residual mass >1cm, immediate RPLND IF residual mass <1cm, consider RPLND vs. surveillance
33
Management of growing teratoma syndrome
immediate surgery
34
Second line options for advanced NSGCT
Conventional-dose chemotherapy (CDCT) w/ TIP for 4 cycles (Preferred - Superior outcomes, but studied in a more favorable/chemo sensitive population) VeIP for 4 cycles (Studied in a more broad group) (vinblastine, ifosfamide, cisplatin *different than VIP) High-dose chemo (HDCT) w/ sequential (2-3) auto-HSCT (Much more toxic, unclear whether HDCT superior to CDCT
35
long term toxicities of treatment for testicular cancer
- secondary malignancies - neuropathy - Raynaud's syndrome
36
Good risk metastatic seminoma management
BEP for 3 cycles
37
Seminoma radiographic findings on US
hypoechoic + well defined
38
seminoma tumor markers
- can have elevated beta-hCG - NO AFP elevation by definition
39
Long term survival rate of seminoma
>90%
40
5 yr survival of good risk seminoma
91%
41
5 yr survival of intermediate risk seminoma
79%
42
5 yr survival of poor risk NSGCT
48%
43
What is stage II disease in testicular cancer
Node positive
44
What is stage III disease in testicular cancer
M1 disease